Subscribe to Search results

The Glasgow RTC, the largest in Scotland, was evaluating the Abbott test.

Published on:

Dr Gunson estimated that the annual costs of routine anti-HCV tests on blood donations in England and Wales would amount to (at least) £5,620,000.

Published on:

Dr Gunson followed up on the £25,000 grant of funding by writing to Dr Kennedy at the NHS Procurement Directorate submitting a draft protocol for a pilot study in Birmingham, Sheffield and Brentwood.

Published on:

Dr Metters wrote a briefing for the Chief Medical Officer, Sir Donald Acheson, informing him of the ACVSB's recommendations and the funding (an estimated £150,000) that would be required for the pilot study.

Published on:

John Canavan wrote a memo to Miss Wheeler regarding the funding of anti-HCV tests. Ortho would not provide free tests for these free trials and as such they would need to be purchased at a total cost of 25,000 oounds . John Canavan was to seek confirmation where these funds would come from.

Published on:

A submission estimated the cost of introducing screening for HCV antibodies at £5.73 million in the first year, with lessening costs subsequently and that it "would add nearly £6 million to the RTCs['] revenue operating costs of approximately £70m pa."

Published on:

The second payment to the Macfarlane Trust proposed in late 1989 was made at a time when "public pressure for some further action" was "intense".

Published on:

Professor Bloom wrote a letter referring to "inaccurate statements in the press" and asserted that "we are unaware of any proven case in our own haemophiliac population" which was a disingenuous half-truth, given his own knowledge of a probable case amongst patients of the Cardiff Centre.

Published on:

Professor Bloom's letter was published by the Haemophilia Society with the comment that "In view of the unduly alarmist reports on AIDS which appeared in the press over the weekend, we are writing to reassure members of the Society about the true position."

Published on:

The first payment made to the Macfarlane Trust was a response to the "considerable parliamentary and public pressure...to do something"

Published on:

Experience of "unsatisfactory communication, including insufficient explanation or apology, is very likely to complicate the grief process."

Published on:

Professor Christine Lee said in an interview "Personally I don't think that faults can be attributed ... I mean cynically I think the patients - the few patients driving this are probably after money actually."

Published on:

In view of the second payment to the Mcfarlane Trust the proposals were the response to "a fast escalating campaign", responding to the campaign in a sympathetic way while containing the consequences for the NHS generally.

Published on:

Susan Douglas for the "Mail on Sunday" wrote: "In May, I pointed out the dangers of importing blood from a country with an AIDS epidemic. And I was viciously attacked for panic-mongering. Must another innocent man die before action is taken?"

Published on:

Andy Burnham explained in his evidence to the Inquiry that the government's response was primarily driven by a fear of financial exposure, and that the UK Government had "comprehensively failed the victims of infected blood" over decades.

Published on:

Dr Jones told BBC Radio 4's "The Reunion" that they apologised over and over and that David Cameron had apologised twice, complaining people were still angry.

Published on:

Dr Peter Jones wrote a complaint to the Press Council regarding a "Mail on Sunday" article with a front page headline "Hospitals using killer blood", calling it sensational and highly exaggerated, causing the Haemophilia Centre to be inundated with calls from worried families.

Published on:

The Press Council adjudicated that the "Mail on Sunday" article using the headline "Hospitals using killer blood" was unacceptably sensational and that the article contained some inaccuracies and was unjustifiably alarmist.

Published on:

The "Mail on Sunday" published an article titled "Hospitals using killer blood".

Published on:

At a meeting of haemophilia centre directors attended by representatives of medical defence organisations, Department of Health and legal advisors of various health authorities to discuss HIV litigation, directors were advised they should agree to act as experts for plaintiffs. If they did not, plaintiffs would have to seek expert advice from outside the directors' group which they said was "undesirable and not in the best interests of anyone".

Published on: